Discovery Value Fund’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Sell |
228,701
-332,860
| -59% | -$3.12M | 4.16% | 3 |
|
|
2025
Q1 | $3.99M | Hold |
561,561
| – | – | 5.66% | 3 |
|
|
2024
Q4 | $6.55M | Hold |
561,561
| – | – | 3.76% | 4 |
|
|
2024
Q3 | $11.5M | Hold |
561,561
| – | – | 5.93% | 3 |
|
|
2024
Q2 | $12.6M | Hold |
561,561
| – | – | 6.39% | 3 |
|
|
2024
Q1 | $15.4M | Hold |
561,561
| – | – | 5.35% | 4 |
|
|
2023
Q4 | $17.1M | Hold |
561,561
| – | – | 7.82% | 2 |
|
|
2023
Q3 | $17.8M | Hold |
561,561
| – | – | 9.73% | 3 |
|
|
2023
Q2 | $22.9M | Hold |
561,561
| – | – | 11.62% | 3 |
|
|
2023
Q1 | $20.9M | Sell |
561,561
-11,389
| -2% | -$424K | 10.54% | 3 |
|
|
2022
Q4 | $20M | Sell |
572,950
-11,533
| -2% | -$402K | 5.79% | 5 |
|
|
2022
Q3 | $32.7M | Hold |
584,483
| – | – | 8.21% | 4 |
|
|
2022
Q2 | $30.3M | Sell |
584,483
-401,690
| -41% | -$20.8M | 6.33% | 5 |
|
|
2022
Q1 | $71.7M | Sell |
986,173
-4,579
| -0.5% | -$333K | 5.28% | 7 |
|
|
2021
Q4 | $117M | Buy |
990,752
+68,341
| +7% | +$8.08M | 4.31% | 6 |
|
|
2021
Q3 | $124M | Sell |
922,411
-7,258
| -0.8% | -$974K | 3.63% | 6 |
|
|
2021
Q2 | $151M | Buy |
929,669
+783,179
| +535% | +$127M | 4.08% | 7 |
|
|
2021
Q1 | $11.8M | Buy |
+146,490
| New | +$11.8M | 0.38% | 13 |
|